Ruedi Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4
Closed -$3.3K 208
2025
Q1
$3.3K Hold
4
﹤0.01% 242
2024
Q4
$3.09K Hold
4
﹤0.01% 245
2024
Q3
$3.54K Sell
4
-5
-56% -$4.5K ﹤0.01% 238
2024
Q2
$8.15K Buy
+9
New +$7.2K ﹤0.01% 198

Other funds holding LLY

Ruedi Wealth Management's LLY Position: Q2 2025 in Review

Ruedi Wealth Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 4 shares — an estimated $3.3K sold.

Ruedi Wealth Management first reported a position in LLY in Q2 2024 and held it in 4 quarters. The position peaked at $8.15K in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Ruedi Wealth Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Ruedi Wealth Management sold 4 Eli Lilly shares in Q2 2025, an estimated $3.3K.
  • Ruedi Wealth Management first reported a position in Eli Lilly in Q2 2024 and held it in 4 quarters.
  • Ruedi Wealth Management's Eli Lilly position peaked at $8.15K in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.